Sangamo BioSciences Inc. (SGMO) Stock Up After Upgrade at Zacks Investment Research

Sangamo BioSciences Inc. (NASDAQ: SGMO) shares rose in value Tuesday Dec 13 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, the Dow DJIA, +0.47% climbed 106 points, or 0.6%, to 19,905. If the Dow finishes higher, it will notch its seventh straight gain.

The S&P 500 index SPX, +0.56% gained 10.45 points, or 0.5%, to 2,267 and the tech-heavy Nasdaq Composite Index COMP, +1.02% added 48 points, or 0.9%, to 5,461.

Both the S&P 500 index SPX, +0.56% and Nasdaq Composite COMP, +1.02% ended lower on Monday, with investors appearing reluctant to push shares higher ahead of the Fed meeting

Analysts at Zacks Investment Research upgraded shares of Sangamo BioSciences Inc. (NASDAQ: SGMO) from Sell to Hold today. With a rating of Hold on the stock, the company has a 52-week high of $9.83. The one-year price target of $7.00 is higher than the opening price of $3.05, that has caused a fair amount of other analysts to issue statements on the stock in recent days. Stock prices sometimes get a jump to the upside when analysts upgrade a stock.

Sangamo BioSciences Inc. (NASDAQ: SGMO) shares last traded at $3.18, a jump of $0.13 or 4.10% compared to the previous closing price. Opening at $3.05, they ranged from $3.00 and $3.25 throughout the day.

Sangamo BioSciences Inc. (NASDAQ: SGMO) now has a market cap of 224.23M.

Sangamo BioSciences Inc. (NASDAQ: SGMO) Average Daily Trading Volume

216,079 shares crossed the trading desk yesterday, below normal, out of a total float 64,598,000. Look for trading volume to pick up in the coming days as investors often use swings in trading volume to determine heavy volume accumulation or distribution by institutional investors.

As with all possible breakouts, investors watch for volume to be at least 40%-50% greater than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts researching thousands of stocks, so it is good corroboration to see them buying a stock you are considering.

Sangamo BioSciences Inc. (NASDAQ: SGMO) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By following the activity of these professional investors—and the moving averages they affect—it allows for traders to make more impactful decisions on trades.

With that in mind, Sangamo BioSciences Inc. (NASDAQ: SGMO) now has a 50-day MA of $3.56 and 200-day MA of $4.81. It has traded in a 52-week range between $2.65 – 9.830 and today’s last price is 67.70%% lower than the 52 week high of $9.83.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors seek companies that have raised their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *